[A16-12] Empagliflozin - Benefit assessment according to §35a Social Code Book V
Last updated 01.06.2016
Commission awarded on 29.02.2016 by the Federal Joint Committee (G-BA).
Digestion, metabolism and hormones
After completion of the assessment by IQWiG the Federal Joint Committee (G-BA) conducts a commenting procedure. This may provide supplementary information and as a result lead to a modified benefit assessment. Further information and the decision on the early benefit assessment can be found on the relevant page of the G-BA website.
|A16-46||Empagliflozin - Addendum to Commission A16-12||Commission completed|
|A14-26||Empagliflozin - Benefit assessment according to §35a Social Code Book V (dossier assessment)||Commission completed|